¹Ú±¤¿­ ¸íÀÇ

³ú°æ»ö, µÎÅë Ä¡·á ¸íÀÇ

¹Ú±¤¿­ ¸íÀÇ

  • ¼Ò ¼Ó
    Áß¾Ó´ëÇб³º´¿ø
  • Áø·á°ú
    ½Å°æ°ú
  • Àü¹®ºÐ¾ß
    ³ú°æ»ö, ³úÇ÷°üÁúȯ, µÎÅë, ¾îÁö·³Áõ

¹Ú±¤¿­ ±³¼ö´Â 10¿© ³â ÀüºÎÅÍ Çѱ¹Àο¡°Ô ¿Ö ÀÌ·¸°Ô ´ë³ú ¼ÒÇ÷°ü ÁúȯÀÌ ¸¹ÀºÁö¸¦ ±Ô¸íÇÏ´Â ¿¬±¸¸¦ ÇØ¿Ô´Ù. ±× °á°ú Ç÷°ü¿¡ Ä®½·ÀÌ Ä§ÂøµÇ¸é¼­ Ç÷°üÀÌ µüµüÇØÁö°í, ÀÌ·Î ÀÎÇØ Ç÷¾ÐÀÌ »ó½ÂÇÔ¿¡ µû¶ó ¼ÒÇ÷°üÀÌ ÅÍÁ® ¹®Á¦¸¦ ÀÏÀ¸Å²´Ù´Â °ÍÀ» È®ÀÎÇÏ°í ºñŸ¹ÎD ºÎÁ·À¸·Î ³úÇ÷°ü¿¡ Ä®½·ÀÌ Ä§ÂøµÈ´Ù´Â °ÍÀ» ±Ô¸íÇß´Ù. ¹Ú ±³¼ö´Â 2015³â ´ë³ú ¼ÒÇ÷°üÁúȯÀ» °¡Áø ȯÀÚÀÇ °æ¿ì ºñŸ¹ÎD ¼öÄ¡°¡ ÀúÇϵŠÀÖ°í, ºñŸ¹ÎD ¼öÄ¡°¡ ÀúÇÏµÈ ³ú°æ»ö ȯÀÚ´Â ³ú ±â´É ȸº¹ Á¤µµ°¡ ÁÁÁö ¾Ê´Ù´Â °ÍÀ» ±¹³» ÃÖÃÊ·Î ±Ô¸í, ³úÁ¹Áß Àü¹® ±¹Á¦ ÇмúÁö ¡®½ºÆ®·ÎÅ©(Stroke)¡¯¿Í ¡®¼¼·¹ºê·Î¹Ù½ºÅ§·¯ µðÁöÁ¿¡ ÀÕµû¶ó ¹ßÇ¥ÇØ ÁÖ¸ñÀ» ¹Þ¾Ò´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¼­¿ï´ë ÀÇ´ë Á¹¾÷

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) Áß¾Ó´ëÇб³ Àǰú´ëÇÐ ½Å°æ°ú ±³¼ö
  • Áß¾Ó´ëÇб³º´¿ø ½Å°æ°ú ±³¼ö
  • Áß¾Ó´ëÇб³º´¿ø ½Å°æ°ú °úÀå
  • Áß¾Ó´ëÇб³º´¿ø ±âȹÁ¶Á¤½ÇÀå
  • Áß¾Ó´ëÇб³º´¿ø ±âȹ ¹× Àü»êÁ¤º¸ ´ã´ç
  • Áß¾Ó´ëÇб³º´¿ø ±¹Á¦Áø·á¼¾ÅÍÀå
  • Harvard Medical School, Research Fellow
  • »ï¼ºÀÇ·á¿ø ½Å°æ°ú ³úÁ¹Áß, µÎÅë ÀüÀÓÀÇ
  • »ï¼º¼­¿ïº´¿ø ¼ö·ÃÀÇ, Àü°øÀÇ

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѽŰæ°úÇÐȸ ÀÌ»ç
  • ´ëÇѳúÁ¹ÁßÇÐȸ ÀÌ»ç
  • ´ëÇѵÎÅëÇÐȸ ÀÌ»ç
  • ´ëÇѳúÁ¹ÁßÇÐȸ ¿ªÇבּ¸È¸ ÀÌ»ç
  • ´ëÇÑÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Áø·áÁöħÀ§¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ New Biomarker for acute ischemic stroke: plasma glycogen phosphorylase isoenzyme BB
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö JNNP
Á¦ ¸ñ Assessment of the Predictive Validity of Etiologic Stroke Classification
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö JAMA Neurol
Á¦ ¸ñ Burden of Intracranial atherosclerosis is associated with long-term vascular outcome in patients with ischemic stroke
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö Stroke
Á¦ ¸ñ 11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer¡¯s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö Clinical Interventions in Aging
Á¦ ¸ñ Characteristics of Elderly-Onset (¡Ã65 years) Headache Diagnosed Using the International Classification of Headache Disorders, Third Edition Beta Version
¹ßÇ¥³âµµ 2016 ¹ßÇ¥Áö J Clin Neurol
Á¦ ¸ñ Relation of serum homocysteine levels to cerebral artery calcification and atherosclerosis
¹ßÇ¥³âµµ 2016 ¹ßÇ¥Áö Atherosclerosis
Á¦ ¸ñ Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone
¹ßÇ¥³âµµ 2016 ¹ßÇ¥Áö Stroke

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

Áß¾Ó´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1800-1114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

Áß¾Ó´ëÇб³º´¿øÀº 727º´»ó°ú 36°³ Áø·á°ú¿Í ¾Ï¼¾ÅÍ, ³úÇ÷°ü¼¾ÅÍ, ½ÉÀåÇ÷°ü¡¤ºÎÁ¤¸Æ¼¾ÅÍ, °©»ó¼±¼¾ÅÍ, ¼ÒÈ­±â¼¾ÅÍ, ôÃß¼¾ÅÍ, È£Èí±â¾Ë·¹¸£±â¼¾ÅÍ µîÀÇ Æ¯¼ºÈ­¼¾ÅÍ·Î ±¸¼ºµÇ¾î 250¿©¸íÀÇ ÀÇ·áÁøÀ» Æ÷ÇÔ °£È£»ç, ÀÇ·á±â»ç µî 2,000¿©¸íÀÇ ±³Á÷¿øÀÌ ÃÖ»óÀÇ ÀÇ·á¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Â ÁßÁõÁúȯ Áß½ÉÀÇ ÀÇ·áÇàÀ§¸¦ Àü¹®À¸·Î ÇÏ´Â ¡®»ó±ÞÁ¾ÇÕº´¿ø¡¯ÀÌ´Ù. º´¿øÀº ¾Ï Ä¡·á¿¡ ¸ÂÃãÇü ÀÎÇÁ¶ó¸¦ ±¸ÃàÇØ ¿ø½ºÅé ¼­ºñ½º¿Í ´ÙÇÐÁ¦ Áø·á¸¦ ÅëÇÑ ÃÖÀûÀÇ ¾Ï Ä¡·á °èȹÀ¸·Î ±â´Ù¸®Áö ¾Ê°í ½Å¼ÓÇÑ ¼ö¼ú ¹× Ç¥Àû Ç׾ϡ¤¹æ»ç¼±Ä¡·á¸¦ ½ÃÇàÇÏ´Â ¾Ï¼¾ÅÍ¿Í ½º¸¶Æ®Æù ±â¹Ý µðÁöÅоϼ¾Å͸¦ µ¿½Ã ¿î¿µÇϸç 24½Ã°£ ¿Â¡¤¿ÀÇÁ ±â¹Ý ¾Ï ȯÀÚ Äɾî¿Í ½É°æ¡¤½É¸® ½ºÆ®·¹½º Ä¡·á½Ã½ºÅÛ±îÁö Á¦°øÇϸç ȯÀÚÀÇ »ýÁ¸À²°ú »îÀÇ Áú Çâ»ó ½Ã۰í ÀÖ´Ù. ¶ÇÇÑ, 24½Ã°£ ÀÀ±Þü°è ¹× ÀΰøÁö´É(AI) ¿µ»óÃÔ¿µ ÆÇµ¶½Ã½ºÅÛÀ» ÅëÇÑ ½Å¼ÓÇϰí Á¤¹ÐÇÑ Áø´ÜÀ¸·Î ¸ÂÃãÇü ½Ã¼ú°ú ¼ö¼ú Ä¡·á°¡ ¸ðµÎ °¡´ÉÇÑ ÇÏÀ̺긮µå Ä¡·á ü°è¸¦ °®Ãá ½ÉÀåÇ÷°ü․ºÎÁ¤¸Æ¼¾ÅÍ¿Í ³úÇ÷°ü¼¾ÅÍ¿¡¼­ ÃÖÀûÀÇ Ä¡·á ¼º°ú¸¦ °ÅµÎ°í ÀÖ´Ù. ±×¸®°í, ½Å°æ¿Ü°ú, Á¤Çü¿Ü°ú Àü¹®Àǰ¡ ÅëÁõŬ¸®´Ð°ú ÀçȰÀÇÇаú¿Í À¯±âÀû °øÁ¶Çϴ ôÃß¼¾ÅÍ´Â 'µ¿Àû Áø·á½Ã½ºÅÛ'À¸·Î ÃÖ»óÀÇ È¯ÀÚ È¸º¹À» µ½´Â´Ù. ÇÑÆí, º´¿øÀº °ÔÀÓ °ú¸ôÀÔÀ¸·Î ÀÏ»ó»ýȰ¿¡ ¿µÇâÀ» ¹Þ´Â À̵éÀÇ Á¤È®ÇÑ ¿øÀÎÀ» Áø´ÜÇϰí Ä¡·áÇϱâ À§ÇØ ±¹³» ÃÖÃÊ·Î ¡®°ÔÀÓ °ú¸ôÀÔ Èú¸µ¼¾ÅÍ¡¯¸¦ ¿ÀÇÂÇØ °¡»óÇö½ÇÄ¡·á¿Í Àü¹® »ó´ã ¹× Ä¡·á ÇÁ·Î±×·¥À» ¿î¿µÇϰí Ä¡·áºñ Áö¿ø µî °ÔÀÓ °ú¸ôÀÔ ¹®Á¦¿¡ ´ëÇÑ ½ÇÁúÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀ¸·Î º´¿øÀº ½ÉÆò¿ø ´ëÀå¾Ï, À§¾Ï, À¯¹æ¾Ï, Æó¾Ï µî ¾ÏÄ¡·á ÀûÁ¤¼º Æò°¡ 1µî±Þ, ±Þ¼º±â³úÁ¹Áß, °ü»óµ¿¸Æ¿ìȸ¼ú, ±Þ¼º½É±Ù°æ»öÁõ, Æó·Å µî ±Þ¼º±âÁúȯ Æò°¡ 1µî±Þ, ÀÀ±ÞÀÇ·á¼¾ÅÍ, ¼ºÀΡ¤½Å»ý¾ÆÁßȯÀÚ½Ç Æò°¡ 1µî±Þ µî Àü ºÐ¾ß¿¡ °ÉÃÄ ÃÖ¿ì¼ö µî±Þ Æò°¡¸¦ ¹Þ¾Æ ±¹³» ÃÖ»óÀ§ ÀÇ·á±â°üÀ¸·Î ±× ¿ì¼ö¼ºÀ» ÀÎÁ¤¹Þ°í ÀÖ´Ù. ƯÈ÷, º¸°Çº¹ÁöºÎ¿Í ½ÉÆò¿ø¿¡¼­ óÀ½À¸·Î ½Ç½ÃÇÑ ¡®ÀÇ·á¼­ºñ½º ȯÀÚ°æÇèÆò°¡¡¯¿¡¼­ ´ëÇѹα¹ Àüü Á¾ÇÕ 1À§ÀÇ À§¾÷À» ´Þ¼ºÇØ ¿ì¸®³ª¶ó º´¿ø Áß È¯Àڵ鿡°Ô °¡Àå Ä£ÀýÇÑ º´¿øÀ¸·Î Æò°¡¹Þ°í ÀÖ´Ù.

Áß¾Ó´ëÇб³º´¿ø		 À̹ÌÁö

¼­¿ïƯº°½Ã µ¿ÀÛ±¸ Èæ¼®·Î 102

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä